Fig. 2

Assessment of cell viability with Exo-srIκB. A The cell viability of PBMCs and SFMCs was assessed using the MTS assay, taking into account the duration of Exo-srIκB treatment. Statistical significance was determined using the Kruskal–Wallis test with Dunn’s multiple comparisons. The presented values represent the mean ± SEM. B A representative gating strategy for flow cytometry was employed to evaluate the survival rate. C Viability dyes were used to stain and measure PBMC and SFMC viability. Statistical significance was determined using a T-test. The presented values represent the mean ± SEM, and symbols represent individual sample. NS, not significant